Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2009-2012

ABSTRACT

AG-013736 (axitinib) in combination with cisplatin and pemetrexed will be evaluated as first-line treatment of patients with locally advanced, recurrent, or metastatic non-squamous, non small cell lung cancer (NSCLC).

URL

https://clinicaltrials.gov/show/NCT00768755

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "AG-013736 (axitinib) in combination with cisplatin and pemetrexed will be evaluated as first-line treatment of patients with locally advanced, recurrent, or metastatic non-squamous, non small cell lung cancer (NSCLC).", 
    "endDate": "2012-03-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00768755", 
    "keywords": [
      "phase study", 
      "first-line treatment", 
      "non small cell lung cancer", 
      "cisplatin", 
      "patient"
    ], 
    "name": "Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00768755"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00006.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.410513.2", 
        "type": "Organization"
      }
    ], 
    "startDate": "2009-01-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1471-2407-14-290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044098763", 
          "https://doi.org/10.1186/1471-2407-14-290"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00768755"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00768755'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00768755'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00768755'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00768755'


 

This table displays all metadata directly associated to this object as RDF triples.

28 TRIPLES      16 PREDICATES      21 URIs      14 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00768755 schema:about anzsrc-for:3142
2 schema:description AG-013736 (axitinib) in combination with cisplatin and pemetrexed will be evaluated as first-line treatment of patients with locally advanced, recurrent, or metastatic non-squamous, non small cell lung cancer (NSCLC).
3 schema:endDate 2012-03-01T00:00:00Z
4 schema:keywords cisplatin
5 first-line treatment
6 non small cell lung cancer
7 patient
8 phase study
9 schema:name Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer
10 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00768755
11 schema:sdDatePublished 2019-03-07T15:23
12 schema:sdLicense https://scigraph.springernature.com/explorer/license/
13 schema:sdPublisher N02375a1ae40946a1a451b2f423a676a7
14 schema:sponsor https://www.grid.ac/institutes/grid.410513.2
15 schema:startDate 2009-01-01T00:00:00Z
16 schema:subjectOf sg:pub.10.1186/1471-2407-14-290
17 schema:url https://clinicaltrials.gov/show/NCT00768755
18 sgo:license sg:explorer/license/
19 sgo:sdDataset clinical_trials
20 rdf:type schema:MedicalStudy
21 N02375a1ae40946a1a451b2f423a676a7 schema:name Springer Nature - SN SciGraph project
22 rdf:type schema:Organization
23 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
24 rdf:type schema:DefinedTerm
25 sg:pub.10.1186/1471-2407-14-290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044098763
26 https://doi.org/10.1186/1471-2407-14-290
27 rdf:type schema:CreativeWork
28 https://www.grid.ac/institutes/grid.410513.2 schema:Organization
 




Preview window. Press ESC to close (or click here)


...